Seelos Therapeutics, Inc. Email Format
Biotechnology ResearchNew York, United States2-10 Employees
Seelos Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing therapies for central nervous system disorders and rare diseases. Its portfolio comprises late-stage clinical assets aimed at treating psychiatric and movement disorders, including orphan diseases, with the goal of addressing unmet medical needs for patients. Based in New York, New York, the company operates within the biotechnology research sector and participates in CNS- and rare-disease-focused developments that may support future clinical outcomes for patients. Seelos’ activities are situated in the clinical development space as it pursues partnerships and business development opportunities, reflecting its position as an early-stage, research-focused biopharmaceutical company. A recent development noted public-facing activity includes leadership changes intended to steer ongoing strategic discussions and potential collaborations.